An open source auto-segmentation algorithm for delineating heart and substructures – Development and validation within a multicenter lung cancer cohort

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

An open source auto-segmentation algorithm for delineating heart and substructures – Development and validation within a multicenter lung cancer cohort. / Olloni, Agon; Lorenzen, Ebbe Laugaard; Jeppesen, Stefan Starup; Diederichsen, Axel; Finnegan, Robert; Hoffmann, Lone; Kristiansen, Charlotte; Knap, Marianne; Milo, Marie Louise Holm; Møller, Ditte Sloth; Pøhl, Mette; Persson, Gitte; Sand, Hella M.B.; Sarup, Nis; Thing, Rune Slot; Brink, Carsten; Schytte, Tine.

I: Radiotherapy and Oncology, Bind 191, 110065, 2024.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Olloni, A, Lorenzen, EL, Jeppesen, SS, Diederichsen, A, Finnegan, R, Hoffmann, L, Kristiansen, C, Knap, M, Milo, MLH, Møller, DS, Pøhl, M, Persson, G, Sand, HMB, Sarup, N, Thing, RS, Brink, C & Schytte, T 2024, 'An open source auto-segmentation algorithm for delineating heart and substructures – Development and validation within a multicenter lung cancer cohort', Radiotherapy and Oncology, bind 191, 110065. https://doi.org/10.1016/j.radonc.2023.110065

APA

Olloni, A., Lorenzen, E. L., Jeppesen, S. S., Diederichsen, A., Finnegan, R., Hoffmann, L., Kristiansen, C., Knap, M., Milo, M. L. H., Møller, D. S., Pøhl, M., Persson, G., Sand, H. M. B., Sarup, N., Thing, R. S., Brink, C., & Schytte, T. (2024). An open source auto-segmentation algorithm for delineating heart and substructures – Development and validation within a multicenter lung cancer cohort. Radiotherapy and Oncology, 191, [110065]. https://doi.org/10.1016/j.radonc.2023.110065

Vancouver

Olloni A, Lorenzen EL, Jeppesen SS, Diederichsen A, Finnegan R, Hoffmann L o.a. An open source auto-segmentation algorithm for delineating heart and substructures – Development and validation within a multicenter lung cancer cohort. Radiotherapy and Oncology. 2024;191. 110065. https://doi.org/10.1016/j.radonc.2023.110065

Author

Olloni, Agon ; Lorenzen, Ebbe Laugaard ; Jeppesen, Stefan Starup ; Diederichsen, Axel ; Finnegan, Robert ; Hoffmann, Lone ; Kristiansen, Charlotte ; Knap, Marianne ; Milo, Marie Louise Holm ; Møller, Ditte Sloth ; Pøhl, Mette ; Persson, Gitte ; Sand, Hella M.B. ; Sarup, Nis ; Thing, Rune Slot ; Brink, Carsten ; Schytte, Tine. / An open source auto-segmentation algorithm for delineating heart and substructures – Development and validation within a multicenter lung cancer cohort. I: Radiotherapy and Oncology. 2024 ; Bind 191.

Bibtex

@article{1d7809f2b5d54dd5a2b8512c14224d5e,
title = "An open source auto-segmentation algorithm for delineating heart and substructures – Development and validation within a multicenter lung cancer cohort",
abstract = "Background and purpose: Irradiation of the heart in thoracic cancers raises toxicity concerns. For accurate dose estimation, automated heart and substructure segmentation is potentially useful. In this study, a hybrid automatic segmentation is developed. The accuracy of delineation and dose predictions were evaluated, testing the method's potential within heart toxicity studies. Materials and Methods: The hybrid segmentation method delineated the heart, four chambers, three large vessels, and the coronary arteries. The method consisted of a nnU-net heart segmentation and partly atlas- and model-based segmentation of the substructures. The nnU-net training and atlas segmentation was based on lung cancer patients and was validated against a national consensus dataset of 12 patients with breast cancer. The accuracy of dose predictions between manual and auto-segmented heart and substructures was evaluated by transferring the dose distribution of 240 previously treated lung cancer patients to the consensus data set. Results: The hybrid auto-segmentation method performed well with a heart dice similarity coefficient (DSC) of 0.95, with no statistically significant difference between the automatic and manual delineations. The DSC for the chambers varied from 0.78-0.86 for the automatic segmentation and was comparable with the inter-observer variability. Most importantly, the automatic segmentation was as precise as the clinical experts in predicting the dose distribution to the heart and all substructures. Conclusion: The hybrid segmentation method performed well in delineating the heart and substructures. The prediction of dose by the automatic segmentation was aligned with the manual delineations, enabling measurement of heart and substructure dose in large cohorts. The delineation algorithm will be available for download.",
keywords = "Automatic segmenation, Breast Cancer, Chambers, Coronary arteries, Heart, Hybrid segmentation, Lung Cancer, Multi-atlas, nnU-net",
author = "Agon Olloni and Lorenzen, {Ebbe Laugaard} and Jeppesen, {Stefan Starup} and Axel Diederichsen and Robert Finnegan and Lone Hoffmann and Charlotte Kristiansen and Marianne Knap and Milo, {Marie Louise Holm} and M{\o}ller, {Ditte Sloth} and Mette P{\o}hl and Gitte Persson and Sand, {Hella M.B.} and Nis Sarup and Thing, {Rune Slot} and Carsten Brink and Tine Schytte",
note = "Publisher Copyright: {\textcopyright} 2023 The Authors",
year = "2024",
doi = "10.1016/j.radonc.2023.110065",
language = "English",
volume = "191",
journal = "Radiotherapy & Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",

}

RIS

TY - JOUR

T1 - An open source auto-segmentation algorithm for delineating heart and substructures – Development and validation within a multicenter lung cancer cohort

AU - Olloni, Agon

AU - Lorenzen, Ebbe Laugaard

AU - Jeppesen, Stefan Starup

AU - Diederichsen, Axel

AU - Finnegan, Robert

AU - Hoffmann, Lone

AU - Kristiansen, Charlotte

AU - Knap, Marianne

AU - Milo, Marie Louise Holm

AU - Møller, Ditte Sloth

AU - Pøhl, Mette

AU - Persson, Gitte

AU - Sand, Hella M.B.

AU - Sarup, Nis

AU - Thing, Rune Slot

AU - Brink, Carsten

AU - Schytte, Tine

N1 - Publisher Copyright: © 2023 The Authors

PY - 2024

Y1 - 2024

N2 - Background and purpose: Irradiation of the heart in thoracic cancers raises toxicity concerns. For accurate dose estimation, automated heart and substructure segmentation is potentially useful. In this study, a hybrid automatic segmentation is developed. The accuracy of delineation and dose predictions were evaluated, testing the method's potential within heart toxicity studies. Materials and Methods: The hybrid segmentation method delineated the heart, four chambers, three large vessels, and the coronary arteries. The method consisted of a nnU-net heart segmentation and partly atlas- and model-based segmentation of the substructures. The nnU-net training and atlas segmentation was based on lung cancer patients and was validated against a national consensus dataset of 12 patients with breast cancer. The accuracy of dose predictions between manual and auto-segmented heart and substructures was evaluated by transferring the dose distribution of 240 previously treated lung cancer patients to the consensus data set. Results: The hybrid auto-segmentation method performed well with a heart dice similarity coefficient (DSC) of 0.95, with no statistically significant difference between the automatic and manual delineations. The DSC for the chambers varied from 0.78-0.86 for the automatic segmentation and was comparable with the inter-observer variability. Most importantly, the automatic segmentation was as precise as the clinical experts in predicting the dose distribution to the heart and all substructures. Conclusion: The hybrid segmentation method performed well in delineating the heart and substructures. The prediction of dose by the automatic segmentation was aligned with the manual delineations, enabling measurement of heart and substructure dose in large cohorts. The delineation algorithm will be available for download.

AB - Background and purpose: Irradiation of the heart in thoracic cancers raises toxicity concerns. For accurate dose estimation, automated heart and substructure segmentation is potentially useful. In this study, a hybrid automatic segmentation is developed. The accuracy of delineation and dose predictions were evaluated, testing the method's potential within heart toxicity studies. Materials and Methods: The hybrid segmentation method delineated the heart, four chambers, three large vessels, and the coronary arteries. The method consisted of a nnU-net heart segmentation and partly atlas- and model-based segmentation of the substructures. The nnU-net training and atlas segmentation was based on lung cancer patients and was validated against a national consensus dataset of 12 patients with breast cancer. The accuracy of dose predictions between manual and auto-segmented heart and substructures was evaluated by transferring the dose distribution of 240 previously treated lung cancer patients to the consensus data set. Results: The hybrid auto-segmentation method performed well with a heart dice similarity coefficient (DSC) of 0.95, with no statistically significant difference between the automatic and manual delineations. The DSC for the chambers varied from 0.78-0.86 for the automatic segmentation and was comparable with the inter-observer variability. Most importantly, the automatic segmentation was as precise as the clinical experts in predicting the dose distribution to the heart and all substructures. Conclusion: The hybrid segmentation method performed well in delineating the heart and substructures. The prediction of dose by the automatic segmentation was aligned with the manual delineations, enabling measurement of heart and substructure dose in large cohorts. The delineation algorithm will be available for download.

KW - Automatic segmenation

KW - Breast Cancer

KW - Chambers

KW - Coronary arteries

KW - Heart

KW - Hybrid segmentation

KW - Lung Cancer

KW - Multi-atlas

KW - nnU-net

U2 - 10.1016/j.radonc.2023.110065

DO - 10.1016/j.radonc.2023.110065

M3 - Journal article

C2 - 38122851

AN - SCOPUS:85181026165

VL - 191

JO - Radiotherapy & Oncology

JF - Radiotherapy & Oncology

SN - 0167-8140

M1 - 110065

ER -

ID: 379711887